Abstract:Purpose Adverse drug events (ADEs) are a significant global public health concern, and they have resulted in high rates of hospital admissions, morbidity, and mortality. Prior to the use of machine learning and deep learning methods, ADEs may not become well recognized until long after a drug has been approved and is widely used, which poses a significant challenge for ensuring patient safety. Consequently, there is a need to develop computational approaches for earlier identification of ADEs not detected during pre-registration clinical trials. Methods This paper presents a state-of-the-art network-based approach that models patients as subgraphs composed of nodes of International Classification of Diseases (ICD) codes and directed edges illustrating disease progression. Four Graph Neural Network (GNN) variants were employed to make sub-graph level predictions that answer three Research Questions (RQ): 1) whether ADE(s) would occur given a patient's prior diagnoses history, 2) when an ADE would occur, and 3) which ADE would occur. The first and second RQs were addressed using a binary classification approach. The third RQ was addressed using a multi-label classification model. Results The proposed network-based approach demonstrated superior performance in predicting ADEs, with the GraphSage model exhibiting the highest accuracy for both RQ 1 (0.8863) and RQ 3 (0.9367), while the Graph Attention Networks (GAT) model was found to perform best for RQ 2 (0.8769). Furthermore, an analysis segmented by ADE classification revealed that while RQs 1 and 3 exhibited minimal variance across different ADE categories, a distinct advantage was observed for categories B, C, and E in the context of RQ 2 when applying this sub-graph method. Conclusion The network-based approach demonstrates the potential of GNNs in supporting the early detection and prevention of ADEs. Accurately predicting ADEs could enable healthcare professionals to make informed clinical decisions, take preventive measures and adjust medication regimens before serious adverse events occur. The proposed prediction method could also lead to optimized usage of healthcare resources by preventing hospital admissions and reducing the overall burden of adverse drug events on the healthcare systems.

PU‐GNN: A Positive‐Unlabeled Learning Method for Polypharmacy Side‐Effects Detection Based on Graph Neural Networks

Polypharmacy side-effect prediction with enhanced interpretability based on graph feature attention network

Advancing medical imaging: detecting polypharmacy and adverse drug effects with Graph Convolutional Networks (GCN)

Modeling polypharmacy side effects with graph convolutional networks

Gorge: graph convolutional networks on heterogeneous multi-relational graphs for polypharmacy side effect prediction

Effective knowledge graph embeddings based on multidirectional semantics relations for polypharmacy side effects prediction

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

DeepPSE: Prediction of polypharmacy side effects by fusing deep representation of drug pairs and attention mechanism

Graph neural network-based subgraph analysis for predicting adverse drug events

Drug-Drug Adverse Effect Prediction with Graph Co-Attention

Polypharmacy side effect prediction based on semi-implicit graph variational auto-encoder

Predicting Drug Effects from High-Dimensional, Asymmetric Drug Datasets by Using Graph Neural Networks: A Comprehensive Analysis of Multitarget Drug Effect Prediction

Tri-graph Information Propagation for Polypharmacy Side Effect Prediction

SGFNNs: Signed Graph Filtering-based Neural Networks for Predicting Drug-Drug Interactions

Graph Distance Neural Networks for Predicting Multiple Drug Interactions

A Deep Learning Approach to the Prediction of Drug Side-Effects on Molecular Graphs

Prediction of drug-drug interaction events using graph neural networks based feature extraction

Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures

Integrating specific and common topologies of heterogeneous graphs and pairwise attributes for drug-related side effect prediction

Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network

Modular multi-source prediction of drug side-effects with DruGNN